Aqua Medical

Treating Gastrointestinal Disease

With Disruptive, Vapor-Based Endoscopic Ablation Therapy

Barrett's Esophagus
Over 3 million people in the U.S. are diagnosed with Barrett's esophagus, a condition that can lead to esophageal cancer, killing over 20,000 people every year.
Learn More
Pancreatic Cysts
Pancreatic cysts can progress to cancer. The only current effective treatment is open surgery, with high morbidity and mortality. The market for an effective endoscopic therapy is over $6B.
Learn More
Type 2 Diabetes
Type 2 diabetes is characterized by chronic hyperglycemia, caused in part by increased insulin resistance. It remains one of the world’s major unmet clinical needs, with over 30 million people suffering and 1.5 million new cases each year in the U.S. alone.
Learn More

Aqua Medical has developed a disruptive, vapor-based, endoscopic, ablation technology to treat gastrointestinal disease and designed to treat GI cancers

The Technology

Aqua Medical’s unique ablation technology consists of high-temperature water vapor created by a radio frequency generator, and delivered endoscopically through proprietary catheters to the GI tract. It is a true platform technology in that a single vapor generator system with two unique catheter types can deliver treatment for multiple diseases throughout the GI tract.

Clinical Application

Barrett's Esophagus

Vapor Ablation of Barrett’s Esophagus

Non-surgical through-the-scope ablation of Barrett’s tissue, intended to prevent its progression toward esophageal cancer.

Play Video
Play Video
Clinical Application

Pancreatic Cysts

Vapor Ablation of Pancreatic Cyst

Non-surgical ablation of pancreatic cysts, designed to prevent their progression toward pancreatic cancer.

Clinical Application

Type 2 Diabetes

Vapor Ablation of Duodenal Mucosa

Non-surgical ablation of duodenal mucosa, intended as an alternative treatment to improve glycemic control for patients with Type 2 Diabetes.

Targeted Clinical Applications

Barrett's Esophagus

Endoscopic ablative therapy is becoming standard of care for the treatment of dysplastic and select non-dysplastic Barrett’s esophagus. Aqua Medical’s platform is intended to be simpler, faster, safer, and easier to use than current therapies.

Pancreatic Cysts

For the pancreatic cyst market, Aqua will offer the first effective endoscopic therapy to treat pancreatic cysts without open surgery and to prevent potential progression to pancreatic cancer.

Type 2 Diabetes

Scientific evidence suggests that duodenal ablation can benefit treatment of metabolic disease, such as Type 2 Diabetes. With its through-the-scope technology, Aqua’s platform is designed to deliver better speed, ease-of-use, and uniform ablation.

Learn more about Aqua Medical's Radio Frequency Vapor Ablation Technology (RFVA)

Contact Us Today

Aqua Medical’s through-the-endoscope Radio Frequency Vapor Ablation (RFVA) system provides a platform for faster, easier to use, more effective outpatient treatment for multiple, unmet clinical needs.

MKTG 1001 Rev A – 093020

AQUA MEDICAL

Aqua Medical, Inc.
191 West Second Street
Santa Ana, California 92701

Regulatory Notice

Aqua Medical RFVA System is FDA cleared for use in the GI tract. Aqua Medical RFVA System is not currently available for sale.

Leadership Team

Lloyd Mencinger
Virender K. Sharma
Greg Wilson
Scott McGill
© 2021 Aqua Medical, Inc., all rights reserved.
Terms of use
Privacy Policy